Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Skip to main content Advertisement Login to your account Search Search BioMed Central articles Search Infectious Agents and Cancer Impact Factor 1.718 Main menu Home About Articles Submission Guidelines Search Submit a manuscript Featured: AORTIC position statement The African Organization for Research and Training in Cancer (AORTIC) publishes a critical appraisal of the state on cancer research and cancer care in Africa including information on the availability of data on cancer burden, screening and prevention for cancer in Africa, cancer care personnel, treatment modalities, and access to cancer care. Read more Articles Recent Most accessed Recent articles RSS 1. Research Article Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria Olugbenga Akindele Silas, Chad J. Achenbach, Lifang Hou, Robert L. Murphy, Julie O. Egesie, Solomon A. Sagay, Oche O. Agbaji, Patricia E. Agaba, Jonah Musa, Agabus N. Manasseh, Ezra D. Jatau, Ayuba M. Dauda, Maxwell O. Akanbi and Barnabas M. Mandong Published on: 5 June 2017 2. Research Article Non-pulmonary cancer risk following tuberculosis: a nationwide retrospective cohort study in Lithuania Ruta Everatt, Irena Kuzmickiene, Edita Davidaviciene and Saulius Cicenas Published on: 31 May 2017 3. Short Report Seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus among HIV-negative people in China Tiejun Zhang, Zhenqiu Liu, Jun Wang, Veenu Minhas, Charles Wood, Gary M. Clifford, Na He and Silvia Franceschi Published on: 30 May 2017 4. Research Article Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer Sylwia Fołtyn, Małgorzata Strycharz-Dudziak, Bartłomiej Drop, Anastazja Boguszewska and Małgorzata Polz-Dacewicz Published on: 30 May 2017 5. Research Article LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer Katharina Beyer, Lars Ivo Partecke, Felicitas Roetz, Herbert Fluhr, Frank Ulrich Weiss, Claus-Dieter Heidecke and Wolfram von Bernstorff Published on: 30 May 2017 View all articles Most accessed articles RSS 1. Review Bacteria and tumours: causative agents or opportunistic inhabitants? Joanne Cummins and Mark Tangney Published on: 28 March 2013 2. Review Simian virus 40 in humans Fernanda Martini, Alfredo Corallini, Veronica Balatti, Silvia Sabbioni, Cecilia Pancaldi and Mauro Tognon Published on: 9 July 2007 3. Letter to the Editor HPV vaccines and cancer prevention, science versus activism Lucija Tomljenovic, Judy Wilyman, Eva Vanamee, Toni Bark and Christopher A Shaw Published on: 1 February 2013 4. Review Role of viruses in the development of breast cancer Kenneth Alibek, Ainur Kakpenova, Assel Mussabekova, Marzhan Sypabekova and Nargis Karatayeva Published on: 2 September 2013 5. Review HPV vaccination programs have not been shown to be cost-effective in countries with comprehensive Pap screening and surgery Judy Wilyman Published on: 12 June 2013 View all articles From the blog View feed Pioneers in Infectious Agents and Cancer Meeting Published on: 02 March 2017 IARC 50th Anniversary Meeting 2016 Published on: 13 June 2016 HCV and cancer collection in Infectious Agents and Cancer Published on: 17 May 2016 Tweets Editors-in-Chief Franco M Buonaguro, Istituto Nazionale Tumori, Naples, Italy Sam M Mbulaiteye, National Cancer Institute, Bethesda, USA Aims and scope Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical and translational research providing an insight into the association between chronic infections and cancer. The journal welcomes submissions in the pathogen-related cancer areas and other related topics, in particular: • HPV and anogenital cancers, as well as head and neck cancers; • EBV and Burkitt lymphoma; • HCV/HBV and hepatocellular carcinoma as well as lymphoproliferative diseases; • HHV8 and Kaposi sarcoma; • HTLV and leukemia; • Cancers in Low- and Middle-income countries. There are established links between specific chronic infections and cancer. Recent advances in genomic and proteomic technologies have accelerated the discovery of novel pathogens, cancer antigens and the molecular pathways involved in disease progression. Several new fields are developing very rapidly, in particular the application of immunogenomics and pharmacogenomics to fight specific cancers, targeting immuno-tolerated cellular/viral molecules by immuno and drug therapy. Infectious Agents and Cancer covers all these areas of biomedical research and any other topics pertinent to the development of therapies for chronic infections and cancer. Editors' quotes “Cancers related to infectious diseases represent a very significant component of the cancer burden in humans spanning from 20% of all malignancies in industrialized countries to 40% in developing countries. Studies on pathogen-related cancers allow the identification of mechanisms relevant to oncogenesis as well as molecular markers for diagnostic/prognostic methods and targets for therapeutic strategies. Furthermore their relevance is due to the concrete possibility of preventive strategies, which are always cost-effective and can usually be implemented with relatively modest investments. The open access policy of Infectious Agents and Cancer represents a key factor to foster an even participation and contribution by Western as well as Eastern/Southern Countries' colleagues.” Franco Buonaguro, Editor-in-Chief, Infectious Agents and Cancer “Cancer is the leading cause of death worldwide. The International Agency for Research on Cancer estimates that about 20% of cancers in developed countries and close to 30% of cancers in developing countries have an infectious etiology. These statistics articulate the imperative to study the epidemiology, biology, and response to treatment of infection-associated cancers to establish sound evidence-based approaches to cancer public policy, prevention, and treatment. The open access policy of Infectious Agents and Cancer represents a key component in the broad efforts to foster, accelerate, and reduce disparity in access to scientific information by scientists, public health authorities, and policy markers worldwide.” Sam M Mbulaiteye, co-Editor-in-Chief, Infectious Agents and Cancer Advertisement Submit a manuscript Affiliated with African Organisation for Research & Training In Cancer (AORTIC) Editorial Board Sign up to article alerts Follow Follow us on Twitter Advertisement Infectious Agents and Cancer ISSN: 1750-9378 Contact us Editorial email: [email protected] Support email: [email protected] Publisher Main Menu Explore journals Get published About BioMed Central By continuing to use this website, you agree to our Terms and Conditions, Privacy statement and Cookies policy. Publisher secondary menu Contact us Jobs Manage article alerts Receive BioMed Central newsletters Leave feedback Language editing for authors Scientific editing for authors Press center Read more on our blogs Policies Licensing Terms and conditions Privacy statement Accessibility Cookies Follow BioMed Central Twitter Facebook Google Plus YouTube LinkedIn Reddit Weibo © 2017 BioMed Central Ltd unless otherwise stated. Part of Springer Nature. We use cookies to improve your experience with our site. More information Close